Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 15291-75-5 | Product Number: G0521
Ginkgolide A
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 10MG |
£46.00
|
2 | 13 |
|
| 50MG |
£165.00
|
2 | 9 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | G0521 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__0H__2__4O__9 = 408.40 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (-20°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 15291-75-5 |
| Reaxys Registry Number | 5318214 |
| PubChem Substance ID | 354335522 |
| MDL Number | MFCD07437829 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
Properties (reference)
| Melting Point | 300 °C(dec.) |
| Maximum Absorption Wavelength | 219(EtOH) nm |
GHS
Related Laws:
| RTECS# | KC9943000 |
Transport Information:
| HS Number | 2932990090 |
Application
Ginkgolide A: A Biologically Active Diterpenoid from Ginkgo biloba Leaves
Ginkgolide A, a biologically active diterpenoid, is one of the major ginkgolides which are the main components in Ginkgo biloba leaf extracts which has been used in traditional medicine. The structures were elucidated in the 1960s by Nakanishi et al. Ginkgolides, including ginkgolide A, have been reported their effects of anti-platelet aggregation, cardioprotective, anti-oxidant, neuroprotective, antistress and so on. (The product is for research purpose only.)
References
- Ginkgolides
- Recent progress in ginkgolide research (a review)
- In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides
- Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761)
- Amyloid-β -induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans
- Determination of ginkgolides and bilobalide in Ginkgo biloba leaves and phytopharmaceuticals
- Quantitative analysis of bilobalide and ginkgolides from Ginkgo biloba leaves and ginkgo products using 1H-NMR
- Simultaneous determination of ginkgolides A, B, C and bilobalide in plasma by LC-MS/MS and its application to the pharmacokinetic study of Ginkgo biloba extract in rats
PubMed Literature
Articles/Brochures
TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.